First Capital Advisors Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$1.06M Sell
9,146
-8
-0.1% -$908 0.55% 47
2023
Q1
$974K Sell
9,154
-221
-2% -$23.9K 0.63% 45
2022
Q4
$1.04M Sell
9,375
-778
-8% -$79.5K 0.71% 42
2022
Q3
$874K Buy
10,153
+476
+5% +$42.5K 0.73% 40
2022
Q2
$882K Buy
+9,677
New +$858K 0.61% 42
2018
Q4
$813K Sell
11,153
-1,267
-10% -$89.4K 0.61% 41
2018
Q3
$841K Sell
12,420
-15
-0.1% -$956 0.52% 44
2018
Q2
$720K Buy
12,435
+3,312
+36% +$187K 0.48% 46
2018
Q1
$474K Sell
9,123
-1,075
-11% -$58.1K 0.27% 75
2017
Q4
$548K Sell
10,198
-986
-9% -$54.7K 0.35% 78
2017
Q3
$683K Buy
11,184
+233
+2% +$14.1K 0.47% 57
2017
Q2
$670K Sell
10,951
-1,059
-9% -$64.5K 0.46% 66
2017
Q1
$728K Buy
12,010
+504
+4% +$30.6K 0.54% 59
2016
Q4
$646K Buy
+11,506
New +$673K 0.6% 43

Other funds holding MRK

First Capital Advisors Group's MRK Position: Q2 2023 in Review

First Capital Advisors Group reduced its Merck (MRK) stake by 0.09% in Q2 2023, selling an estimated $908 and leaving 9,146 shares worth $1.06M. The position accounts for 0.55% of the portfolio, ranked #47.

First Capital Advisors Group first reported a position in MRK in Q4 2016 and has held it in 14 quarters since. 3,255 funds tracked by Wall St. Rank hold MRK as of Q2 2023.

  • First Capital Advisors Group held 9,146 shares of Merck worth $1.06M as of Q2 2023.
  • First Capital Advisors Group sold 8 Merck shares in Q2 2023, an estimated $908.
  • Merck made up 0.55% of First Capital Advisors Group's portfolio in Q2 2023, its #47 holding.
  • First Capital Advisors Group first reported a position in Merck in Q4 2016 and has held it in 14 quarters since.
  • 3,255 funds tracked by Wall St. Rank held Merck as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.